Entertainment
View All
Philadelphia’s Chris’ Jazz Café Hosts ‘Jazz for Good’ Fundraiser Supporting Young Musicians
PHILADELPHIA, PA — An evening of soulful sound and meaningful impact is coming to Center City as The Heart of Jazz Foundation teams up with Chris’ Jazz Café for a …
Lifestyle
View All
At the Crossroads of Everything: The Constant Motion of Exton
The light changes, but no one really stops. Cars glide through the intersection in practiced rhythm—east to west along Route 30, north to south on Route 100—each movement part of …
Pennsylvania
View All
PennDOT Seeks Private Ideas for Transportation Projects
HARRISBURG, PA — Private companies have until the end of April to propose transportation projects or services to the state under a program that allows businesses to partner with Pennsylvania …
National
View All
New Mortgage Data Release Expands Public Access
WASHINGTON, D.C. — Detailed mortgage lending data for 2025 are now publicly available online, giving consumers, researchers, and policymakers expanded access to information about how loans are issued across the …
Latest Articles
View All
New Mortgage Data Release Expands Public Access
WASHINGTON, D.C. — Detailed mortgage lending data for 2025 are now publicly available online, giving consumers, researchers, and policymakers expanded access to information about how loans are issued across the …
Cabaletta Reports Results, Advances Rese-Cel Autoimmune Program
PHILADELPHIA, PA — Cabaletta Bio Inc. (Nasdaq: CABA) recently reported fourth-quarter and full-year 2025 results and said it is advancing clinical development of its rese-cel cell therapy program for autoimmune …
Arbutus Reports Results, Announces $2.25B Moderna Settlement
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) recently reported its fourth-quarter and full-year 2025 results and disclosed a global settlement with Moderna valued at up to $2.25 billion, the …
Novartis to Acquire Synnovation Unit in Deal Worth Up to $3 Billion
WILMINGTON, DE — Novartis has agreed to acquire Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics, in a deal valued at up to $3 billion to expand its oncology pipeline, the …
Ashland Raises Prices Across Product Lines Amid Cost Pressures
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) recently implemented price increases across multiple product lines globally in response to rising energy, raw material, and logistics costs tied to ongoing conflict …